|
2024 Conference Publication Therapeutic targeting of a-specific PI3K improves chemotherapy efficacy by inhibiting hepatic stellate cell activation in liver cancerRuan, Qi, Cao, Lu, Yang, Haotian, Burke, Leslie, Bridle, Kim, Crawford, Darrell and Liang, Xiaowen (2024). Therapeutic targeting of a-specific PI3K improves chemotherapy efficacy by inhibiting hepatic stellate cell activation in liver cancer. Gastroenterological Society of Australia (GESA) Australian Gastroenterology Week (AGW) 2024, Adelaide, SA Australia, 14-16 September 2024. Richmond, VIC Australia: John Wiley & Sons. |
|
2023 Conference Publication Reactive oxygen species-mediated hepatic stellate cell activation via PI3K in liver cancerRuan, Qi, Cao, Lu, Yang, Haotian, Burke, Leslie, Bridle, Kim, Crawford, Darrell and Liang, Xiaowen (2023). Reactive oxygen species-mediated hepatic stellate cell activation via PI3K in liver cancer. EASL Congress 2023, Vienna, Austria, 21 - 24 June 2023. Amsterdam, Netherlands: Elsevier. |
